Filing Flows › Champions Oncology (CSBR) › Q4 FY26 › vs Q3 FY26
Champions Oncology (CSBR) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Champions Oncology's revenue fell $2.7M (-16%) from $16.6M in Q3 FY26 to $13.8M in Q4 FY26.
Champions Oncology, Q4 FY26: revenue $13.8M (+12% year over year), operating margin -3.8%, net loss $667K, operating cash flow −$2.0M. The chart draws each line against Q3 FY26, the increases inside each band.
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $13.8M | $16.6M | −$2.7M | -16% |
| Net loss | $667K | $278K | $389K | +140% |
| Costs & expenses | $14.5M | $16.9M | −$2.3M | -14% |
| Operating costs | $14.4M | $16.8M | −$2.5M | -15% |
| Income tax | $172K | $42K | $130K | +310% |
| Cost of revenue | $6.8M | $8.8M | −$2.0M | -23% |
| Research & development | $2.1M | $2.3M | −$156K | -7% |
| Sales & marketing | $2.8M | $2.7M | $132K | +5% |
| General & admin | $2.6M | $3.0M | −$342K | -11% |
| Operating cash sources | $2.7M | $2.1M | $552K | +26% |
| Depreciation & amortization | $300K | $341K | −$41K | -12% |
| Share-based compensation | $357K | $423K | −$66K | -16% |
| Cash used in operations | $2.0M | $1.3M | $659K | +49% |
| Net loss absorbed | $667K | $278K | $389K | +140% |
| Working capital & other | $2.0M | $1.8M | $163K | +9% |
Questions
How much did Champions Oncology's revenue grow quarter over quarter in Q4 FY26?
Champions Oncology's revenue fell $2.7M (-16%) from $16.6M in Q3 FY26 to $13.8M in Q4 FY26.